Genotyping in Antimalarial Trials: A Review
Author Information
Author(s): Collins William J, Greenhouse Bryan, Rosenthal Philip J, Dorsey Grant
Primary Institution: Department of Medicine, University of California, San Francisco
Hypothesis
How do different genotyping methods affect estimates of antimalarial drug efficacy in clinical trials?
Conclusion
Standardized genotyping methods are needed to improve the accuracy of antimalarial drug efficacy estimates across different trials.
Supporting Evidence
- The study found that 24% of trials used genotyping to adjust efficacy estimates.
- Genotyping methods varied widely, affecting the classification of treatment outcomes.
- Trials in Africa had the highest proportion of subjects with recurrent parasitaemia.
Takeaway
This study looked at how scientists check if malaria treatments are working by using genetic tests, and found that different testing methods can change the results.
Methodology
A systematic review of clinical antimalarial efficacy trials published from 1995–2005 was conducted, focusing on the use of genotyping methods.
Potential Biases
Different interpretations of genotyping results may lead to misclassification of treatment outcomes.
Limitations
Variability in genotyping methods and lack of standardization may affect the comparability of results.
Participant Demographics
Studies included human subjects with uncomplicated falciparum malaria.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website